Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 29/11/2020
SIETES contiene 93175 citas

 
 
 1 a 17 de 17 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Ostengaard L, Lundh A, Tjørnhøj-Thomsen T, Abdi S, Gelle MHA, Stewart LA, Boutron I, Hróbjartsson A. nfluence and management of conflicts of interest in randomised clinical trials: qualitative interview study. BMJ 2020;371:27 de octubre. [Ref.ID 103760]
3.Enlace a cita originalTiene citas relacionadas
Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JPA, Straus S, Thorlund K, Jansen JP, Mulrow C, Catalá-López F, Gotzsche PC, Kickersin K, Boutron I, Altman DG, Moher D. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 2015;162:777-84. [Ref.ID 99279]
4. Cita con resumen
Riveros C, Dechartre A, Perrodeau A, Haneef R, Boutron I, Ravaud P. Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals. PLOS Medicine 2013;10:e1001566. [Ref.ID 96706]
5. Cita con resumen
Dechartres A, Trinquart L, Boutron I, Ravaud P. Influence of trial sample size on treatment effect estimates: meta-epidemiological study. BMJ 2013;346:15. [Ref.ID 95533]
6. Cita con resumen
Hróbjartsson A, Thomsen ASS, Emanuelsson F, Tendal B, Hilden J, Boutron I, Ravaud P, Brorson S. Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors. BMJ 2012;344:20. [Ref.ID 92611]
7.Tiene citas relacionadas Cita con resumen
Dechartres A, Boutron I, Trinquart L, Charles P, Ravaud P. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study. Ann Intern Med 2011;155:39-51. [Ref.ID 91363]
8. Cita con resumen
Glasziou P, Chalmers I, Altman DG, Bastian H, Boutron I, Brice A, Jamtvedt G, Farmer A, Ghersi D, Groves T, Heneghan C, Hill S, Lewin S, Michie S, Perera R, Pomeroy V, Tilson J, Shepperd S, Williams JW. Taking healthcare interventions from trial to practice. BMJ 2010;341:384-7. [Ref.ID 89188]
9. Cita con resumen
Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA 2010;303:2058-64. [Ref.ID 88510]
10. Cita con resumen
Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA 2010;303:2058-64. [Ref.ID 88447]
12.Tiene citas relacionadas Cita con resumen
Pitrou I, Boutron I, Ahmad N, Ravaud P. Reporting of safety results in published reports of randomized controlled trials. Arch Intern Med 2009;169:1756-61. [Ref.ID 87035]
13. Cita con resumen
Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 2009;302:977-84. [Ref.ID 86703]
14.Tiene citas relacionadas
Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, for the CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008;148:295-309. [Ref.ID 82250]
15.Enlace a cita original Cita con resumen
Boutron I, Guittet L, Estellat C, Moher D, Hróbjartsson A, et al.. Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. PLOS Medicine 2007;4:61. [Ref.ID 79271]
16.
Ethgen M, Boutron I, Baron G, Giraudeau B, Sibilia J, Ravaud P. Reporting of harm in randomized, controlled trials of nonpharmacologic treatment of rheumatic disease. Ann Intern Med 2005;143:20-5. [Ref.ID 74284]
Seleccionar todas
 
 1 a 17 de 17